Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
GEMCITABINE HYDROCHLORIDE, CISPLATIN, AVELUMAB, CISPLATIN, CISPLATIN, CISPLATIN, CARBOPLATIN, CARBOPLATIN, GEMCITABINE HYDROCHLORIDE
Fondazione Telethon ETS
metastatic or locally advanced urothelial cancer
1 trial -
Guanfacine hydrochloride (TAK-503)
Takeda
Attention Deficit Hyperactivity Disorder
1 trial -
HUMAN SERUM ALBUMIN, SODIUM CHLORIDE
The George Institute
descompensated hepatic cirrosis
1 trial -
IPTACOPAN HYDROCHLORIDE, IPTACOPAN
Novartis Pharmaceuticals
C3 Glomerulopathy or idiopathic immune-complex membranoproliferative glomerulonephritis
1 trial -
Ketamine Hydrochloride
United Therapeutics Europe Ltd
Hemorrhage
1 trial -
Ketamine Hydrochloride
NORTHWEST BIOTHERAPEUTICS INC
Revision Spine Surgery
1 trial -
LIDOCAINE HYDROCHLORIDE, MORPHINE HYDROCHLORIDE
Pierre Fabre Australia Pty Ltd
sickle cell anaemia
1 trial -
Midodrine Hydrochloride
Takeda
Hypotension, Orthostatic
2 trials -
Oxycodone Hydrochloride
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Analgesia, Patient-Controlled
1 trial -
PDD regimen: doxorubicin hydrochloride iposome, bortizomib and dexamethasone
The First People's Hospital of Lianyungang
Multiple Myeloma
1 trial -
Placebo suspension is identical to Symbioflor®2 liquid formulation in appearance, weight and composition, with the exception that the active ingredient will be omitted. Placebo constitutes are sodium chloride, magnesium sulphate 7H2O, potassium chloride, calcium chloride 2H2O, magnesium chloride 6H2O, and purified water, Symbioflor 2 Tropfen zum Einnehmen, Suspension
Alphapharm Pty Ltd
Irritable Bowel Syndrome
1 trial -
Placebo used in this trial is a foodgrade, redried potato starch. It is a white powder with bland taste and free from objectionable odours. Insoluble in water with a temperature below 50 °C and most organic solvents, solution is slightly hazy. The product is intended for use in food., POTATO STARCH, SODIUM CHLORIDE, AMILORIDE
Disc Medicine
Autosomal Dominant Polycystic Kidney Disease
1 trial -
ROPIVACAINE , SODIUM CHLORIDE
Disc Medicine
Urolithiasis
1 trial -
SODIUM CHLORIDE, Ondansetron Morningside 4 mg orodispergeerbare tabletten, Ondansetron 2 mg/ml Solution for Injection, Ketanest® S 5 mg/ml - Ampullen
Shanghai Reinovax Biologics Co.,LTD
Endometriosis
1 trial -
SODIUM CHLORIDE, ROPIVACAINE HYDROCHLORIDE
Disc Medicine
Total Hip Arthroplasty / THA
1 trial -
Sertraline Hydrochloride
The First People's Hospital of Lianyungang
COVID-19 Vaccine Adverse Reaction
1 trial -
Sodium Chloride 0.9%, Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)
Disc Medicine
Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)
1 trial -
Sodium Chloride Fresenius Kabi Italia 0,9 % Solution for infusion, MabThera 500 mg concentrate for solution for infusion
Disc Medicine
Systemic sclerosis
1 trial -
Sodium Chloride Fresenius Kabi Italia 0.9 % Solution for infusion , DENOSUMAB, Sodium Fluoride (18F) Life Radiopharma 0,1 - 4 GBq/ml solution injectable
Disc Medicine
Fibrous dysplasia/McCune-Albright syndrome
1 trial -
Suboxone, Buprenorphine Hydrochloride + Naloxone, SCH 484
Indivior Pty Ltd
Opiate Dependence
1 trial -
Sulfato de Magnesio Altan 150 mg/ml solución inyectable y para perfusión EFG, LIDOCAINE HYDROCHLORIDE, Dexdor 100 micrograms/ml concentrate for solution for infusion, KETOLAR 50 mg/ml solución inyectable.
The George Institute
Obesity
1 trial -
TILMANOCEPT, TILMANOCEPT, GALLIUM (68GA) CHLORIDE, TECHNETIUM (99MTC)
Disc Medicine
Oral cancer
1 trial -
The placebo MDI is formulated as a suspension of spray-dried porous particles (consisting of 1,2-distearoyl-sn-glycero-3-phosphocholine [DSPC] and calcium chloride) in a hydrofluoroalkane propellant (HFA-134a). The placebo MDI uses the same excipients as active product but with absence of the active pharmaceutical ingredient (API)., Trixeo Aerosphere 5 micrograms/7.2 micrograms/160 micrograms pressurised inhalation, suspension
AstraZeneca AB
Chronic Obstructive Pulmonary Disease
1 trial -
Tirofiban hydrochloride sodium chloride injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Branch Atheromatous Disease
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources